Auger and Conversion Electron Therapy with In-111 Pentetreotide in Hepatocellural Carcinoma

In a 42 year male, with hepatocellural carcinoma, confirmed by biopsy and a positive for somatostatin receptor liver scan, without any symptoms of neuroendocrine activity, it was decided to be treated with high therapeutic doses of [In-111-DTPA-D-Phe1] Octreotide [Mallinckrodt Br, Petten] and to abandon the conventional and, in the majority of the cases, hopeless cytostatic therapy.